The Board of Directors of Chemclin Diagnostics Co., Ltd. has authorized a buyback plan on November 28, 2023.
Chemclin Diagnostics Co., Ltd.
Equities
688468
CNE100005311
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.57 CNY | +3.79% |
|
-9.88% | -39.11% |
05-21 | Shareholders to Cut Up to 2% Stake in Chemclin Diagnostics | MT |
05-03 | Chemclin Diagnostics Launches Homegrown Immunodetection Kits | MT |
1st Jan change | Capi. | |
---|---|---|
-39.11% | 359M | |
-8.60% | 11.98B | |
-5.68% | 8B | |
+7.10% | 5.85B | |
+27.10% | 5.54B | |
-15.84% | 3.84B | |
+10.70% | 2.66B | |
-60.21% | 2.62B | |
-8.22% | 2.33B | |
+14.66% | 2B |
- Stock Market
- Equities
- 688468 Stock
- News Chemclin Diagnostics Co., Ltd.
- Chemclin Diagnostics Co., Ltd. authorizes a Buyback Plan.